We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Brazil Breaks Patent On Merck's AIDS Drug

Law360 (May 4, 2007, 12:00 AM EDT) -- Brazil’s president has signed a compulsory license that overrides Merck & Co. Inc.’s patent on HIV/AIDS drug Efavirenz so that the country can import a generic version of the drug from India.

The move by President Luiz Inacio Lula da Silva on Friday marked the first time Brazil broke a patent to obtain more affordable drugs for its AIDS prevention program. Thailand has taken a similar step, and countries like Canada and Italy have exercised a provision in World Trade Organization rules to defy drug patents...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.